Hikma Pharmaceuticals PLC Annual Report 2009
Since Hikma was founded, we have grown into a successful multinational pharmaceutical group. Our business today is diverse in its product line and the breadth of its geographic coverage. This diversification will ensure that we maintain our track record of strong growth
Chairman's statement
In 2010, Hikma once again delivered a strong performance, increasing revenue by 14.8% and diluted earnings per share by 25.2%.
Read more of the Chairman's reviewCEO’s review
In 2010, Hikma continued its track record of doubling sales every four years. This success rests on the hard work of Hikma employees globally and Hikma’s diversified business model.
Read more of the CEO's reviewGroup at a glance
We develop, manufacture and market generic and in-licensed pharmaceutical products within three core businesses. Our operations span 49 countries and focus on key therapeutic areas...
Read more about the groupDelivering our strategy
A focus on quality sales is delivering results ac ross our portfolio of branded generic and in-licensed products.
Read more about how we deliver our strategy
